Automate Your Wheel Strategy on TLRY
With Tiblio's Option Bot, you can configure your own wheel strategy including TLRY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TLRY
- Rev/Share 0.9101
- Book/Share 2.9748
- PB 0.1675
- Debt/Equity 0.126
- CurrentRatio 2.6177
- ROIC -0.2236
- MktCap 522589607.0
- FreeCF/Share -0.0894
- PFCF -6.4332
- PE -0.4836
- Debt/Assets 0.1011
- DivYield 0
- ROE -0.2882
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 5
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Good Supply Introduces New Monsters Resin Vapes: Full Spectrum Highs
Published: February 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
TORONTO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. company (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, has announced the introduction of Good Supply's latest product innovation: Monsters 1,000mg THC Resin Vapes. Building on the success of their popular 1,000mg THC pre-rolls, the Good Supply Monsters collection is now expanding into the vape category with two strain x strain pairings: Grape Daddy Kush and Super Lemon Guy.
Read More
Tilray stock price crashes below $1: buy the dip or sell the rip?
Published: February 18, 2025 by: Invezz
Sentiment: Negative
Tilray stock price has continued to crash this year even as most shares have roared back. TLRY has crashed by 30% this year, making it one of the top laggards on Wall Street and in Canada, where it is also listed.
Read More
Tilray: Improved Balance Sheet And Reasonable Valuation (Rating Upgrade)
Published: February 16, 2025 by: Seeking Alpha
Sentiment: Positive
Upgraded Tilray Brands to Buy due to improved balance sheet and reasonable valuation relative to tangible book value and projected adjusted EBITDA. Despite recent all-time lows, TLRY shows potential for short-term gains, with technical resistance levels at $1.20 and $1.34. Q2 results were disappointing, but revenue grew due to acquisitions; net debt significantly reduced from $309 million to $31 million over the past year.
Read More
Here Is How Marijuana Stocks Are Impact By The Cannabis Industry
Published: February 14, 2025 by: MarijuanaStocks
Sentiment: Neutral
The growth of the cannabis industry is set to have a profound impact on marijuana stocks in 2025. With an increasing number of states and countries legalizing cannabis, the market is expanding rapidly. This has led to the potential of creating lucrative investment opportunities. Cannabis stocks trade with high levels of volatility. This has made it tough to gauge market patterns and trends as things can shift without warning. For some time many depend on the volatility to be able to make a profit.
Read More
Blue Point Brewing Announces 5th Annual Shakedown on Main Street Festival
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
PATCHOGUE, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Blue Point Brewing Company , Long Island's original craft brewery and a Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY), proudly announces its 5th annual Shakedown on Main Street arts and music festival, on Saturday, May 17, 2025, at its Patchogue, New York brewery.
Read More
Tilray Expands Medical Cannabis Portfolio in Germany
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the expansion of its industry-leading medical cannabis extract portfolio in Germany. Tilray's new medical cannabis offerings in Germany includes the introduction of an additional product size for its top-selling medical cannabis extract, along with a new formulation aimed at addressing the diverse needs of patients and healthcare providers.
Read More
Tilray Brands Enhances Global Cannabis Supply Chain
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
Tilray Brands Enhances Global Cannabis Supply Chain Increases Industry-Leading Capacity to Meet Global Demand, Driving Growth Across Canada and Europe
Read More
About Tilray Brands, Inc. (TLRY)
- IPO Date 2018-07-19
- Website https://www.tilray.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Irwin David Simon
- Employees 2650